This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Jan 13;369(9556):105-6; author reply 106.

doi: 10.1016/S0140-6736(07)60067-1.

Prevention of vascular events in atrial fibrillation

Huai yong Cheng

PMID: 17223469
DOI: 10.1016/S0140-6736(07)60067-1

Comment

Prevention of vascular events in atrial fibrillation

Huai yong Cheng. Lancet. 2007.

. 2007 Jan 13;369(9556):105-6; author reply 106.

doi: 10.1016/S0140-6736(07)60067-1.

Author

Huai yong Cheng

PMID: 17223469
DOI: 10.1016/S0140-6736(07)60067-1

No abstract available

PubMed Disclaimer

Comment on

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.
ACTIVE Writing Group of the ACTIVE Investigators; Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S. ACTIVE Writing Group of the ACTIVE Investigators, et al. Lancet. 2006 Jun 10;367(9526):1903-12. doi: 10.1016/S0140-6736(06)68845-4. Lancet. 2006. PMID: 16765759 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information